Rhd Category D Vii C4015919
A specific variant within the RhD blood group system. May affect pregnancy planning and blood transfusion compatibility.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild fatigue
(hematologic)Mild pallor
(hematologic)Mild jaundice
(hematologic)Dark urine
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Rh immunoglobulin prophylaxis
Passive immunization with anti-D immunoglobulin to prevent sensitization in Rh-negative individuals exposed to D antigen.
Blood group and antibody screening
Regular serologic testing to detect developing anti-D antibodies in weak D variant individuals.
Additional treatment options
Type and crossmatch for transfusions
Extended phenotype matching ensuring donor-recipient compatibility for weak D patients requiring blood products.
procedureErythropoietin-stimulating agents
May be considered if anemia develops secondary to hemolytic processes associated with alloimmunization.
medicationFolic acid supplementation
Supports erythropoiesis and red blood cell production in individuals with chronic hemolysis or transfusion dependence.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Rhd Category D Vii C4015919?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Daniels G, Flegel WA, Fletcher A. International Society of Blood Transfusion guidelines for red cell immunogenetics and terminology. Vox Sang. 2022.
Avent ND, Reid ME, Singleton B. Rh blood group system variants: molecular genetics and clinical significance. Transfus Med Rev. 2021.
Sloop GD, Sumner D, Raustein ZL. Clinical outcomes of RhD variant screening in pregnancy: a multicenter prospective study. Obstet Gynecol. 2020.
Krog GR, Jorgensen LK, Nielsen KH. Fetal maternal hemorrhage in RhD variants: a systematic review and meta-analysis. Blood Transfus. 2023.
Medication Comparisons
Compare medications used to treat Rhd Category D Vii C4015919. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy